Skip to content

A case registry study of Chinese medicine high colonic dialysis in the treatment of chronic kidney disease in the real world

A case registry study of Chinese medicine high colonic dialysis in the treatment of chronic kidney disease in the real world

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006519
Enrollment
Unknown
Registered
2022-08-20
Start date
2022-08-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Basic treatment + oral administration of traditional Chinese medicine decoction:Adjust lifestyle, actively treat primary diseases, control related chronic diseases and high-risk factors, etc. + refer
Basic treatment + oral administration of traditional Chinese medicine decoction + high colon dialysis treatment of traditional Chinese medicine:Adjust lifestyle, actively treat primary diseases, contr
Basic treatment:Adjust lifestyle, actively treat primary disease, control related chronic diseases and high-risk factors, etc.
Basic treatment + Chinese medicine high colon dialysis treatment:Adjust lifestyle, actively treat primary diseases, control related chronic diseases and high-risk factors, etc. high colon dialysis pre

Sponsors

Sichuan Academy of Traditional Chinese Medicine Institute of Traditional Chinese Medicine/Sichuan Second Hospital of Traditional Chinese&#32
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients who met the diagnostic criteria of Western medicine for CKD stages 1-5 (non-dialysis stage), aged =18 years, were included. Gender is not limited; I or my family members are willing to accept and cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: Pregnant or lactating women; patients with severe heart and cerebrovascular system diseases and allergic constitution or allergic to this drug; malignant tumors, entering hemodialysis, liver cirrhosis, severe heart failure; acute kidney disease; accompanied by severe depression and Patients with severe mental illness such as schizophrenia; those who cannot correctly understand the investigator's questions and respond normally.

Design outcomes

Primary

MeasureTime frame
Six items of blood routine, liver and kidney function, coagulation, electrolytes and blood lipids;

Secondary

MeasureTime frame
Kidney and Renal Vascular Ultrasound;security indicators;

Countries

China

Contacts

Public ContactXudongxian
656265669@qq.com13880273464

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026